• 1995

Company Description

Alchemia Limited is a listed Australian biopharmaceutical company with an FDA approved drug and a late stage oncology product.

Alchemia Limited is a listed Australian biopharmaceutical company (ASX:ACL) with an FDA approved drug (Fondaparinux sodium) and a late stage oncology product pipeline derived from the HyACT platform. In addition, Alchemia has a drug discovery platform, VAST, derived from Alchemia’s chemistry expertise.